379 related articles for article (PubMed ID: 32534826)
1. Molecular identification, phylogenetic analysis and antifungal susceptibility patterns of Aspergillusnidulans complex and Aspergillusterreus complex isolated from clinical specimens.
Mohamadnia A; Salehi Z; Namvar Z; Tabarsi P; Pourabdollah-Toutkaboni M; Rezaie S; Marjani M; Moniri A; Abtahian Z; Mahdaviani SA; Mortezaee V; Askari E; Sharifynia S
J Mycol Med; 2020 Sep; 30(3):101004. PubMed ID: 32534826
[TBL] [Abstract][Full Text] [Related]
2. Molecular Identification and In Vitro Antifungal Susceptibility of Aspergillus Isolates Recovered from Otomycosis Patients in Western China.
Zhang L; Wang X; Houbraken J; Mei H; Liao W; Hasimu H; Liu W; Deng S
Mycopathologia; 2020 Jun; 185(3):527-535. PubMed ID: 32346838
[TBL] [Abstract][Full Text] [Related]
3. Genetic diversity and antifungal susceptibility patterns of Aspergillus nidulans complex obtained from clinical and environmental sources.
Tavakoli M; Rivero-Menendez O; Abastabar M; Hedayati MT; Sabino R; Siopi M; Zarrinfar H; Nouripour-Sisakht S; van der Lee H; Valadan R; Meletiadis J; Yazdani Charati J; Seyedmousavi S; Alastruey-Izquierdo A
Mycoses; 2020 Jan; 63(1):78-88. PubMed ID: 31609022
[TBL] [Abstract][Full Text] [Related]
4. Multicenter Study of Susceptibility of Aspergillus Species Isolated from Iranian University Hospitals to Seven Antifungal Agents.
Badiee P; Boekhout T; Zarei Mahmoudabadi A; Mohammadi R; Ayatollahi Mousavi SA; Najafzadeh MJ; Soltani J; Hashemi J; Diba K; Ghadimi-Moghadam A; Salimi-Khorashad AR; Shokohi T; Amin Shahidi M; Ghasemi F; Jafarian H
Microbiol Spectr; 2022 Jun; 10(3):e0253921. PubMed ID: 35579442
[TBL] [Abstract][Full Text] [Related]
5. Patterns of susceptibility of Aspergillus isolates recovered from patients enrolled in the Transplant-Associated Infection Surveillance Network.
Baddley JW; Marr KA; Andes DR; Walsh TJ; Kauffman CA; Kontoyiannis DP; Ito JI; Balajee SA; Pappas PG; Moser SA
J Clin Microbiol; 2009 Oct; 47(10):3271-5. PubMed ID: 19692558
[TBL] [Abstract][Full Text] [Related]
6. In-vitro antifungal susceptibility testing of lanoconazole and luliconazole against Aspergillus flavus as an important agent of invasive aspergillosis.
Omran SM; Taghizadeh-Armaki M; Zarrinfar H; Hedayati MT; Abastabar M; Moqarabzadeh V; Ansari S; Saber S; Hoseinnejad A; Miri A; Verweij PE; Seyedmousavi S
J Infect Chemother; 2019 Feb; 25(2):157-160. PubMed ID: 30241879
[TBL] [Abstract][Full Text] [Related]
7. Luliconazole, an alternative antifungal agent against Aspergillus terreus.
Zargaran M; Taghipour S; Kiasat N; Aboualigalehdari E; Rezaei-Matehkolaei A; Zarei Mahmoudabadi A; Shamsizadeh F
J Mycol Med; 2017 Sep; 27(3):351-356. PubMed ID: 28483449
[TBL] [Abstract][Full Text] [Related]
8. Identification by Molecular Methods and Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry and Antifungal Susceptibility Profiles of Clinically Significant Rare Aspergillus Species in a Referral Chest Hospital in Delhi, India.
Masih A; Singh PK; Kathuria S; Agarwal K; Meis JF; Chowdhary A
J Clin Microbiol; 2016 Sep; 54(9):2354-64. PubMed ID: 27413188
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the Sensititre YeastOne and CLSI M38-A2 Microdilution Methods in Determining the Activity of Amphotericin B, Itraconazole, Voriconazole, and Posaconazole against Aspergillus Species.
Wang HC; Hsieh MI; Choi PC; Wu CJ
J Clin Microbiol; 2018 Oct; 56(10):. PubMed ID: 30093391
[TBL] [Abstract][Full Text] [Related]
10. Prospective survey of Aspergillus species isolated from clinical specimens and their antifungal susceptibility: A five-year single-center study in Japan.
Toyotome T; Saito S; Koshizaki Y; Komatsu R; Matsuzawa T; Yaguchi T
J Infect Chemother; 2020 Feb; 26(2):321-323. PubMed ID: 31564504
[TBL] [Abstract][Full Text] [Related]
11. Molecular epidemiology and in-vitro antifungal susceptibility of Aspergillus terreus species complex isolates in Delhi, India: evidence of genetic diversity by amplified fragment length polymorphism and microsatellite typing.
Kathuria S; Sharma C; Singh PK; Agarwal P; Agarwal K; Hagen F; Meis JF; Chowdhary A
PLoS One; 2015; 10(3):e0118997. PubMed ID: 25781896
[TBL] [Abstract][Full Text] [Related]
12. In vitro survey of triazole cross-resistance among more than 700 clinical isolates of Aspergillus species.
Pfaller MA; Messer SA; Boyken L; Rice C; Tendolkar S; Hollis RJ; Diekema DJ
J Clin Microbiol; 2008 Aug; 46(8):2568-72. PubMed ID: 18562581
[TBL] [Abstract][Full Text] [Related]
13. In vitro antifungal activity of amphotericin B and 11 comparators against Aspergillus terreus species complex.
Vaezi A; Fakhim H; Arastehfar A; Shokohi T; Hedayati MT; Khodavaisy S; Rezaei-Matehkolaei A; Badiee P; Hagen F; Lass-Flörl C; Dannaoui E; Meis JF; Badali H
Mycoses; 2018 Feb; 61(2):134-142. PubMed ID: 29064123
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology and Antifungal Susceptibility Profile of
Cho SY; Lee DG; Kim WB; Chun HS; Park C; Myong JP; Park YJ; Choi JK; Lee HJ; Kim SH; Park SH; Choi SM; Choi JH; Yoo JH
J Clin Microbiol; 2019 Jul; 57(7):. PubMed ID: 31018982
[TBL] [Abstract][Full Text] [Related]
15. A prospective survey of Aspergillus spp. in respiratory tract samples: Species identification and susceptibility patterns.
Castro C; Galán-Sanchez F; Linares MJ; Tejero R; Ruiz M; Serrano ML; Rodríguez-Iglesias M; Martín-Mazuelos E;
Med Mycol; 2019 Jun; 57(4):412-420. PubMed ID: 30289467
[TBL] [Abstract][Full Text] [Related]
16. In vitro susceptibilities of Aspergillus spp. causing otomycosis to amphotericin B, voriconazole and itraconazole.
Kaya AD; Kiraz N
Mycoses; 2007 Nov; 50(6):447-50. PubMed ID: 17944704
[TBL] [Abstract][Full Text] [Related]
17. Increased frequency of non-fumigatus Aspergillus species in amphotericin B- or triazole-pre-exposed cancer patients with positive cultures for aspergilli.
Lionakis MS; Lewis RE; Torres HA; Albert ND; Raad II; Kontoyiannis DP
Diagn Microbiol Infect Dis; 2005 May; 52(1):15-20. PubMed ID: 15878437
[TBL] [Abstract][Full Text] [Related]
18. A prospective survey of Aspergillus spp. in respiratory tract samples: prevalence, clinical impact and antifungal susceptibility.
Mortensen KL; Johansen HK; Fuursted K; Knudsen JD; Gahrn-Hansen B; Jensen RH; Howard SJ; Arendrup MC
Eur J Clin Microbiol Infect Dis; 2011 Nov; 30(11):1355-63. PubMed ID: 21541671
[TBL] [Abstract][Full Text] [Related]
19. Aspergillus citrinoterreus, a new species of section Terrei isolated from samples of patients with nonhematological predisposing conditions.
Guinea J; Sandoval-Denis M; Escribano P; Peláez T; Guarro J; Bouza E
J Clin Microbiol; 2015 Feb; 53(2):611-7. PubMed ID: 25502530
[TBL] [Abstract][Full Text] [Related]
20. [Antifungal susceptibilities of Aspergillus spp. strains isolated from invasive aspergillosis cases].
Gürcan S; Tikveşli M; Eryildiz C; Evci C; Ener B
Mikrobiyol Bul; 2010 Apr; 44(2):273-8. PubMed ID: 20549962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
